Filing Flows › Comparisons › SXTP vs BTAIQ
60 Degrees Pharmaceuticals vs BioXcel Therapeutics: SXTP and BTAIQ compared
60 Degrees Pharmaceuticals is the larger company: $208K of revenue in its latest quarter (Q2 2026) against $182K for BioXcel Therapeutics (Q2 2026). 60 Degrees Pharmaceuticals is growing faster (+106% against +52% a year earlier).
Where the money goes: SXTP and BTAIQ
60 Degrees Pharmaceuticals (SXTP) · Q2 2026
60 Degrees Pharmaceuticals, Q2 2026: revenue $208K (+106% year over year), net loss $2.3M, operating cash flow −$2.2M. The chart follows the revenue to costs, profit and cash.
BioXcel Therapeutics (BTAIQ) · Q2 2026
BioXcel Therapeutics, Q2 2026: revenue $182K (+52% year over year), net loss $14.7M, operating cash flow −$6.1M. The chart follows the revenue to costs, profit and cash.
| 60 Degrees Pharmaceuticals (SXTP) | BioXcel Therapeutics (BTAIQ) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $208K | $182K |
| Revenue growth, Y/Y | +106% | +52% |
| Operating margin | n/m | n/m |
| Net earnings | −$2.3M | −$14.7M |
| Operating cash flow | −$2.2M | −$6.1M |
Questions
Which is bigger, 60 Degrees Pharmaceuticals or BioXcel Therapeutics?
60 Degrees Pharmaceuticals is the larger company: $208K of revenue in its latest quarter (Q2 2026) against $182K for BioXcel Therapeutics (Q2 2026).
Is 60 Degrees Pharmaceuticals or BioXcel Therapeutics growing faster?
60 Degrees Pharmaceuticals is growing faster (+106% against +52% a year earlier).
More: 60 Degrees Pharmaceuticals earnings · how 60 Degrees Pharmaceuticals makes money · BioXcel Therapeutics earnings · how BioXcel Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.